All Stories

  1. Risk of treatment-related deaths with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a meta-analysis of 41 randomized controlled trials

    Article • OncoTargets and Therapy, October 2014, Dove Medical Press

    Dr xuan wu

  2. Serum proteomic study on EGFR-TKIs target treatment for patients with NSCLC

    Article • OncoTargets and Therapy, October 2013, Taylor & Francis

    jakevi zhang, Dr xuan wu